ONC EPS Estimates
BeOne Medicines Ltd.
$372.90
+$21.41(+6.09%)
39
Overall
25
Value
36
Tech
57
Quality
Market Cap
$39.69B
Volume
339.75K
52W Range
$253.95 - $385.22
Target Price
$427.03
ONC EPS estimates: the consensus estimate for BeOne Medicines Ltd.'s current fiscal year is $8.99 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ONC EPS Estimates
- EPS estimate, current quarter
- $2.34
- EPS estimate, next quarter
- $2.09
- EPS estimate, current year
- $8.99
- EPS estimate, next year
- $13.69
- EPS growth, 3-year
- +28.75%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.20 |
| 2024 | $-6.11 |
| 2023 | $-8.45 |
| 2022 | $-1.49 |
| 2021 | $-1.17 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ONC | $372.90 | +6.1% | 339.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |